A pan-KRAS inhibitor compound
The present invention relates to a pan-KRAS inhibitor compound represented by formula (I) or formula (II) and a pharmaceutical composition containing the compound, and the use of compound of formula (I) or formula (II) for preventing and/or treating cancer, tumor, inflammatory disease, autoimmune di...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CHENG Wanli LI Feifan YANG Han HE Nanhai LIU Canfeng WU Peng CHEN Kaixuan LV Meng CHEN Yufeng LIU Shuaishuai |
| description | The present invention relates to a pan-KRAS inhibitor compound represented by formula (I) or formula (II) and a pharmaceutical composition containing the compound, and the use of compound of formula (I) or formula (II) for preventing and/or treating cancer, tumor, inflammatory disease, autoimmune disease or immune- mediated disease. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LU505464B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LU505464B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LU505464B13</originalsourceid><addsrcrecordid>eNrjZJB1VChIzNP1DnIMVsjMy8hMyizJL1JIzs8tyC_NS-FhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfE-oaYGpiZmJk6GxoRVAAD3iSK_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A pan-KRAS inhibitor compound</title><source>esp@cenet</source><creator>CHENG Wanli ; LI Feifan ; YANG Han ; HE Nanhai ; LIU Canfeng ; WU Peng ; CHEN Kaixuan ; LV Meng ; CHEN Yufeng ; LIU Shuaishuai</creator><creatorcontrib>CHENG Wanli ; LI Feifan ; YANG Han ; HE Nanhai ; LIU Canfeng ; WU Peng ; CHEN Kaixuan ; LV Meng ; CHEN Yufeng ; LIU Shuaishuai</creatorcontrib><description>The present invention relates to a pan-KRAS inhibitor compound represented by formula (I) or formula (II) and a pharmaceutical composition containing the compound, and the use of compound of formula (I) or formula (II) for preventing and/or treating cancer, tumor, inflammatory disease, autoimmune disease or immune- mediated disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240513&DB=EPODOC&CC=LU&NR=505464B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240513&DB=EPODOC&CC=LU&NR=505464B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHENG Wanli</creatorcontrib><creatorcontrib>LI Feifan</creatorcontrib><creatorcontrib>YANG Han</creatorcontrib><creatorcontrib>HE Nanhai</creatorcontrib><creatorcontrib>LIU Canfeng</creatorcontrib><creatorcontrib>WU Peng</creatorcontrib><creatorcontrib>CHEN Kaixuan</creatorcontrib><creatorcontrib>LV Meng</creatorcontrib><creatorcontrib>CHEN Yufeng</creatorcontrib><creatorcontrib>LIU Shuaishuai</creatorcontrib><title>A pan-KRAS inhibitor compound</title><description>The present invention relates to a pan-KRAS inhibitor compound represented by formula (I) or formula (II) and a pharmaceutical composition containing the compound, and the use of compound of formula (I) or formula (II) for preventing and/or treating cancer, tumor, inflammatory disease, autoimmune disease or immune- mediated disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB1VChIzNP1DnIMVsjMy8hMyizJL1JIzs8tyC_NS-FhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfE-oaYGpiZmJk6GxoRVAAD3iSK_</recordid><startdate>20240513</startdate><enddate>20240513</enddate><creator>CHENG Wanli</creator><creator>LI Feifan</creator><creator>YANG Han</creator><creator>HE Nanhai</creator><creator>LIU Canfeng</creator><creator>WU Peng</creator><creator>CHEN Kaixuan</creator><creator>LV Meng</creator><creator>CHEN Yufeng</creator><creator>LIU Shuaishuai</creator><scope>EVB</scope></search><sort><creationdate>20240513</creationdate><title>A pan-KRAS inhibitor compound</title><author>CHENG Wanli ; LI Feifan ; YANG Han ; HE Nanhai ; LIU Canfeng ; WU Peng ; CHEN Kaixuan ; LV Meng ; CHEN Yufeng ; LIU Shuaishuai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LU505464B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHENG Wanli</creatorcontrib><creatorcontrib>LI Feifan</creatorcontrib><creatorcontrib>YANG Han</creatorcontrib><creatorcontrib>HE Nanhai</creatorcontrib><creatorcontrib>LIU Canfeng</creatorcontrib><creatorcontrib>WU Peng</creatorcontrib><creatorcontrib>CHEN Kaixuan</creatorcontrib><creatorcontrib>LV Meng</creatorcontrib><creatorcontrib>CHEN Yufeng</creatorcontrib><creatorcontrib>LIU Shuaishuai</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHENG Wanli</au><au>LI Feifan</au><au>YANG Han</au><au>HE Nanhai</au><au>LIU Canfeng</au><au>WU Peng</au><au>CHEN Kaixuan</au><au>LV Meng</au><au>CHEN Yufeng</au><au>LIU Shuaishuai</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A pan-KRAS inhibitor compound</title><date>2024-05-13</date><risdate>2024</risdate><abstract>The present invention relates to a pan-KRAS inhibitor compound represented by formula (I) or formula (II) and a pharmaceutical composition containing the compound, and the use of compound of formula (I) or formula (II) for preventing and/or treating cancer, tumor, inflammatory disease, autoimmune disease or immune- mediated disease.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_LU505464B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | A pan-KRAS inhibitor compound |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T12%3A30%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHENG%20Wanli&rft.date=2024-05-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELU505464B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |